Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) shares saw unusually-high trading volume on Monday . Approximately 8,000 shares changed hands during mid-day trading, an increase of 29% from the previous session’s volume of 6,217 shares.The stock last traded at $8.00 and had previously closed at $8.02.
Oxford BioMedica Price Performance
The company has a debt-to-equity ratio of 3.08, a quick ratio of 1.67 and a current ratio of 1.89. The company’s 50-day moving average is $8.19 and its two-hundred day moving average is $6.38.
About Oxford BioMedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Further Reading
- Five stocks we like better than Oxford BioMedica
- What is a buyback in stocks? A comprehensive guide for investors
- These 2 Energy Titans Just Scored Major Wins to Close Out November
- Top Stocks Investing in 5G Technology
- Analog Devices Moves Higher as Super-Cycle Gains Momentum
- What to Know About Investing in Penny Stocks
- Microsoft Stock Faces An AI-Driven Physics Problem
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
